# Use of Intravitreal Bevacizumab in Patients With Diffuse Diabetic Macular Edema

> **NCT00417716** · PHASE3 · WITHDRAWN · sponsor: **Asociación para Evitar la Ceguera en México**

## Conditions studied

- Diabetes Mellitus Type 2
- Diabetic Macular Edema

## Interventions

- **DRUG:** Intravitreal Bevacizumab

## Key facts

- **NCT ID:** NCT00417716
- **Lead sponsor:** Asociación para Evitar la Ceguera en México
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2005-09
- **Primary completion:** 2005-09
- **Final completion:** 2006-05
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Poor accrual
- **Last updated:** 2024-06-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00417716

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00417716, "Use of Intravitreal Bevacizumab in Patients With Diffuse Diabetic Macular Edema". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00417716. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*